Not yet recruitingInterventionalPhase 3Last updated Aug 12, 2026

Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT)

A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of KN3835 vs Placebo in the Treatment of Flexible/Semi-Flexible Hammertoe

Overview

ClinicalTrials.gov ID: NCT07759362
Lead Sponsor: Endo USA Inc., a Keenova Therapeutics CompanyINDUSTRY
Brief Summary: The primary purpose of this study is to assess the efficacy, safety, and tolerability of KN3835 compared to placebo in the treatment of flexible/semi-flexible HMT.
Study Type: Interventional

Status

Overall Status: Not yet recruiting
Start Date: Aug 2026Estimated
Primary Completion Date: Dec 2027Estimated
Completion Date: Dec 2027Estimated

Study Record Dates

First Submitted: Aug 7, 2026
First Submitted that Met QC Criteria: Aug 7, 2026
First Posted: Aug 12, 2026Actual
Last Update Submitted that Met QC Criteria: Aug 7, 2026
Last Update Posted: Aug 12, 2026Actual
Last Verified: Aug 2026

NCT01604070Completed

Study to Evaluate Safety, of NextraTM in Surgery to Fuse the Proximal-interphalangeal- Joints

NCT01927952Withdrawn

A Prospective Randomized Comparison of Three Methods for Fixation of Hammertoes

NCT01589679Terminated

Contracture Reduction Following Bunionectomy: a Longitudinal, Controlled Trial

NCT07220434Not yet recruiting

TO Plate Fixation vs. External Fixator Comparison (HTO Plate vs. ExFix Study)

NCT02638480Unknown status

Effectiveness of KneeMD on Flexion Contracture in Total Knee Arthroplasty Patients

NCT02452671Terminated

Observational Plan to Obtain Clinical Experience and Follow up Data on the Use of the ProxiFuse Hammer Toe Device